News and Events

Phage Refinery has received a grant from the National Science Foundation. This Phase I STTR grant provides funds to accelerate the transfer of our licensed technology from UTHSCSA laboratories to operations within our New Venture Incubator space at UT San Antonio. This in turn provides the resources needed to isolate and qualify hundreds of environmental…

Phage Refinery has been chosen to compete in the BioFest Invest 2024 Pitch Competition on April 17, 2024. Founding CEO Bill Tolhurst will be presenting a brief overview of the company and where we’re headed to local and regional investors specifically focused on healthcare opportunities. If you’re there, be sure to look him up!

Phage Refinery is very excited to announce its PureFage™ Service, PureFage enables researchers and therapy development organizations to quickly and easily isolate and characterize phage for their target bacteria. Leveraging the technology and know-how from decades of world-class phage research, isolation can be performed on demand in days without the distraction and capital expense required…